TOGETHER Trial
The TOGETHER Trial is an international clinical trial platform investigating repurposed drugs for the treatment of COVID-19.
Participants
Investigators
| Name | Affiliation | Notes |
|---|---|---|
| David Boulware1) | University of Minnesota | - |
Funding
The TOGETHER Trial has received funding from:
Results
Publications
Links
External links
Links to sort
1)
Together Trial. Platform Life Sciences. Retrieved November 15, 2022, from http://archive.today/2022.11.15-224049/https://platformlifesciences.com/together-trial/
2)
Reis, G., Silva, E. A. S. M., Silva, D. C. M., Thabane, L., Milagres, A. C., Ferreira, T. S., dos Santos, C. V. Q., Campos, V. H. S., Nogueira, A. M. R., de Almeida, A. P. F. G., Callegari, E. D., Neto, A. D. F., Savassi, L. C. M., Simplicio, M. I. C., Ribeiro, L. B., Oliveira, R., Harari, O., Forrest, J. I., Ruton, H., & Sprague, S. (2022). Effect of Early Treatment with Ivermectin among Patients with Covid-19. New England Journal of Medicine, 386(18). https://doi.org/10.1056/nejmoa2115869
3)
Field, J. (2022, May 16). The FTX Foundation supports the global expansion of the Trial of the Year award winning TOGETHER Trial. Cision Newswire. http://archive.today/2022.11.21-221002/https://www.newswire.ca/news-releases/the-ftx-foundation-supports-the-global-expansion-of-the-trial-of-the-year-award-winning-together-trial-891722751.html